Pharmacokinetics expert Gallo to
direct new research facility

The School of Pharmacy has appointed James Gallo, an expert in pharmacokinetics, director of the new Center for Bioanalysis and Pharmacokinetics and professor of pharmaceutical sciences. Gallo joins Temple from Fox Chase Cancer Center.

Pharmacokinetics, the study of how the body absorbs, distributes, metabolizes and eliminates drugs, helps researchers determine the ideal dose of a drug: how much, how often and when.

“Each drug follows a unique path to perform its action. Pharmacokinetics, a major part of the drug development process, reveals the course that a drug takes over time by measuring its presence in human fluids,” Gallo explained. “We need to understand this path to be able to design the safest, most effective drug.”

The center, staffed and equipped to perform both pharmacokinetic

(what the body does to drugs) and pharmacodynamic (what drugs do to the body) analyses, is the first such facility at Temple. Scientists and researchers at Temple and beyond need this type of analytic support for drug research. The centerpiece of the new facility is a tandem mass spectrometer, a very sophisticated, precise tool used to measure extremely small quantities of drugs.

Gallo’s own research is primarily focused on experimental brain tumor treatments. He is specifically looking at how to enhance drug accumulation in tumors through an understanding of drug interactions and drug transport. It’s not enough that a drug can attack brain tumor cells in the lab dish; the drug needs to be able to overcome the impervious blood-brain barrier that surrounds the brain and to reach the tumors in sufficient amounts.

To this end, Gallo and his team utilize various experimental systems, such as genetic knock-out models, to characterize the role various cellular barriers might play in drug distribution to tumors.

Another aspect of Gallo’s research is collaborating with clinicians on studies of new anti-cancer agents in phase I and phase II clinical trials.

“In these types of studies, we will characterize the pharmacokinetic and pharmacodynamic properties of new drugs and combinations to learn the optimal ways to use them,” Gallo said. “All of these measurements can be turned into mathematical models that help us select improved drug dosage schedules.”

Gallo received a B.S. in pharmacy from Massachusetts College of Pharmacy, a Pharm.D. from the University of Florida College of Pharmacy and a Ph.D. in pharmaceutical sciences from University of Arizona College of Pharmacy.

Return to Pharmacy News